NCT00141778View on ClinicalTrials.gov

Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

455

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

July 31, 2010

Study Completion Date

August 31, 2010

Conditions
Atrial Fibrillation
Interventions
DRUG

Placebo

Matching placebo taken once a day

DRUG

Ramipril

Taken orally, once a day

DRUG

Spironolactone

Taken orally, once a day

Trial Locations (1)

37232

Vanderbilt University, Nashville

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Vanderbilt University

OTHER

NCT00141778 - Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF) | Biotech Hunter | Biotech Hunter